These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FMD vs. pharmacological approaches for endothelial function. Tanaka H J Appl Physiol (1985); 2005 Oct; 99(4):1627. PubMed ID: 16160030 [No Abstract] [Full Text] [Related]
3. The 1989 Ulf von Euler lecture. Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Furchgott RF Acta Physiol Scand; 1990 Jun; 139(2):257-70. PubMed ID: 2164317 [No Abstract] [Full Text] [Related]
4. An effect of LP-805 as an inducer of endothelium-derived nitric oxide on systemic vasodilation in vivo. Inazu M; Kishii K; Morimoto T; Momota Y; Tujitani M Jpn J Pharmacol; 1992; 58 Suppl 2():393P. PubMed ID: 1507624 [No Abstract] [Full Text] [Related]
5. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Goto C; Higashi Y; Kimura M; Noma K; Hara K; Nakagawa K; Kawamura M; Chayama K; Yoshizumi M; Nara I Circulation; 2003 Aug; 108(5):530-5. PubMed ID: 12874192 [TBL] [Abstract][Full Text] [Related]
6. [Nitric oxide-dependent endogenous and exogenous vasodilators. The mechanism of action of nitrates]. Machado AP; Alcântara P Rev Port Cardiol; 1995 Jan; 14(1):61-71. PubMed ID: 7695956 [TBL] [Abstract][Full Text] [Related]
9. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Heitzer T; Krohn K; Albers S; Meinertz T Diabetologia; 2000 Nov; 43(11):1435-8. PubMed ID: 11126415 [TBL] [Abstract][Full Text] [Related]
10. Evidence for endothelium-derived relaxing factor/nitric oxide in equine digital arteries. Cogswell AM; Johnson PJ; Adams HR Am J Vet Res; 1995 Dec; 56(12):1637-41. PubMed ID: 8599526 [TBL] [Abstract][Full Text] [Related]
11. [The scientific impact of the nitric oxide discovery as vasodilator and endogenous antithrombotic agent]. Evora PR Arq Bras Cardiol; 1993 Jul; 61(1):3-5. PubMed ID: 8285862 [No Abstract] [Full Text] [Related]
12. Ulster says 'NO'; explosion, resistance and tolerance. Nitric oxide and the actions of organic nitrates. Johnston GD Ulster Med J; 1998 Nov; 67(2):79-90. PubMed ID: 9885543 [No Abstract] [Full Text] [Related]
13. Ischaemia enhances the role of Ca2+-activated K+ channels in endothelium-dependent and nitric oxide-mediated dilatation of the rat hindquarters vasculature. Woodman OL; Wongsawatkul O Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):254-60. PubMed ID: 15053823 [TBL] [Abstract][Full Text] [Related]
14. Vascular wall energetics in arterioles during nitric oxide-dependent and -independent vasodilation. Shibata M; Qin K; Ichioka S; Kamiya A J Appl Physiol (1985); 2006 Jun; 100(6):1793-8. PubMed ID: 16497835 [TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide-induced impairment of nitric oxide-mediated vasorelaxation and protective effects of nitric oxide synthesis inhibitors in isolated rat mesenteric arteries. Miike T; Kanda M; Kunishiro K; Shirahase H Arzneimittelforschung; 2010; 60(6):315-9. PubMed ID: 20648920 [TBL] [Abstract][Full Text] [Related]
19. Simulated microgravity impairs vascular contractility: role of nitric oxide-dependent vasodilator mechanisms. Sangha DS; Vaziri ND; Ding Y; Han S; Alem N; Chen YA; Purdy RE Proc West Pharmacol Soc; 1999; 42():5-7. PubMed ID: 10697672 [No Abstract] [Full Text] [Related]
20. Bobbing along on the crest of a wave: NO ascends hamster cheek pouch arterioles. Fleming I Circ Res; 2003 Jul; 93(1):9-11. PubMed ID: 12855671 [No Abstract] [Full Text] [Related] [Next] [New Search]